Cargando…

Apigenin, a Single Active Component of Herbal Extract, Alleviates Xerostomia via ERα-Mediated Upregulation of AQP5 Activation

Xerostomia is a common symptom in menopausal women, suggesting the role of sex steroids in disease development. Shreds of literature had reported the potential use of herbal extracts to relieve xerostomia. However, a cocktail of multiple components in herbal extract makes it difficult to understand...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wei, Cao, Tingting, Pathak, Janak L., Liu, Xintong, Mao, Tianjiao, Watanabe, Nobumoto, Li, Xiaomeng, Zhang, Manli, Li, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899471/
https://www.ncbi.nlm.nih.gov/pubmed/35264956
http://dx.doi.org/10.3389/fphar.2022.818116
_version_ 1784663923977355264
author Wei, Wei
Cao, Tingting
Pathak, Janak L.
Liu, Xintong
Mao, Tianjiao
Watanabe, Nobumoto
Li, Xiaomeng
Zhang, Manli
Li, Jiang
author_facet Wei, Wei
Cao, Tingting
Pathak, Janak L.
Liu, Xintong
Mao, Tianjiao
Watanabe, Nobumoto
Li, Xiaomeng
Zhang, Manli
Li, Jiang
author_sort Wei, Wei
collection PubMed
description Xerostomia is a common symptom in menopausal women, suggesting the role of sex steroids in disease development. Shreds of literature had reported the potential use of herbal extracts to relieve xerostomia. However, a cocktail of multiple components in herbal extract makes it difficult to understand the exact mechanism of action. Aquaporin5 (AQP5), the specific aquaporin expressed in salivary glands, plays an important role in salivary secretion as a downstream of estrogen signaling. In this study, we aimed to unravel a single active herbal component as a therapeutic for xerostomia and investigate its mechanism of action. The effects of apigenin (flavonoid), dauricine (alkaloids), protopine (alkaloids), and lentinan (polysaccharides) on AQP5 transcription were screened in vitro. Only apigenin robustly induced AQP5 transcription and expression, and this effect was even robust compared to the effect of estradiol (E2, a positive control). Overexpression of estrogen receptor α (ERα) in the human salivary gland cell line (HSG) upregulated the AQP5 transcription and expression and the knockdown ERα reversed this effect, suggesting the role of ERα signaling on AQP5 activation in HSG cells. Docking results showed apigenin-specific binding sites in ERα. We further analyzed the therapeutic effect of apigenin on ovariectomized mice as a xerostomia model. The saliva secretion in the xerostomia group was reduced to one-third of the sham group, whereas the apigenin or E2 treatment for 12 weeks reversed this effect. Meanwhile, the water consumption in the xerostomia group was augmented obviously compared to the sham group, whereas the water consumption in the apigenin and E2 group was declined to the level of the sham group. Immunohistochemistry of submandibular glands revealed the downregulation of AQP5 expression in xerostomia mice compared to control. Apigenin, or E2 treatment, upregulated AQP5 expression in xerostomia mice. In conclusion, apigenin, a single active component of herbal extract, upregulated AQP5 expression in HSG cells via activation of ERα signaling and restored saliva flow rates in OVX mice. These results revealed apigenin as a single active component of herbal extract with the potential to treat xerostomia.
format Online
Article
Text
id pubmed-8899471
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88994712022-03-08 Apigenin, a Single Active Component of Herbal Extract, Alleviates Xerostomia via ERα-Mediated Upregulation of AQP5 Activation Wei, Wei Cao, Tingting Pathak, Janak L. Liu, Xintong Mao, Tianjiao Watanabe, Nobumoto Li, Xiaomeng Zhang, Manli Li, Jiang Front Pharmacol Pharmacology Xerostomia is a common symptom in menopausal women, suggesting the role of sex steroids in disease development. Shreds of literature had reported the potential use of herbal extracts to relieve xerostomia. However, a cocktail of multiple components in herbal extract makes it difficult to understand the exact mechanism of action. Aquaporin5 (AQP5), the specific aquaporin expressed in salivary glands, plays an important role in salivary secretion as a downstream of estrogen signaling. In this study, we aimed to unravel a single active herbal component as a therapeutic for xerostomia and investigate its mechanism of action. The effects of apigenin (flavonoid), dauricine (alkaloids), protopine (alkaloids), and lentinan (polysaccharides) on AQP5 transcription were screened in vitro. Only apigenin robustly induced AQP5 transcription and expression, and this effect was even robust compared to the effect of estradiol (E2, a positive control). Overexpression of estrogen receptor α (ERα) in the human salivary gland cell line (HSG) upregulated the AQP5 transcription and expression and the knockdown ERα reversed this effect, suggesting the role of ERα signaling on AQP5 activation in HSG cells. Docking results showed apigenin-specific binding sites in ERα. We further analyzed the therapeutic effect of apigenin on ovariectomized mice as a xerostomia model. The saliva secretion in the xerostomia group was reduced to one-third of the sham group, whereas the apigenin or E2 treatment for 12 weeks reversed this effect. Meanwhile, the water consumption in the xerostomia group was augmented obviously compared to the sham group, whereas the water consumption in the apigenin and E2 group was declined to the level of the sham group. Immunohistochemistry of submandibular glands revealed the downregulation of AQP5 expression in xerostomia mice compared to control. Apigenin, or E2 treatment, upregulated AQP5 expression in xerostomia mice. In conclusion, apigenin, a single active component of herbal extract, upregulated AQP5 expression in HSG cells via activation of ERα signaling and restored saliva flow rates in OVX mice. These results revealed apigenin as a single active component of herbal extract with the potential to treat xerostomia. Frontiers Media S.A. 2022-02-21 /pmc/articles/PMC8899471/ /pubmed/35264956 http://dx.doi.org/10.3389/fphar.2022.818116 Text en Copyright © 2022 Wei, Cao, Pathak, Liu, Mao, Watanabe, Li, Zhang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wei, Wei
Cao, Tingting
Pathak, Janak L.
Liu, Xintong
Mao, Tianjiao
Watanabe, Nobumoto
Li, Xiaomeng
Zhang, Manli
Li, Jiang
Apigenin, a Single Active Component of Herbal Extract, Alleviates Xerostomia via ERα-Mediated Upregulation of AQP5 Activation
title Apigenin, a Single Active Component of Herbal Extract, Alleviates Xerostomia via ERα-Mediated Upregulation of AQP5 Activation
title_full Apigenin, a Single Active Component of Herbal Extract, Alleviates Xerostomia via ERα-Mediated Upregulation of AQP5 Activation
title_fullStr Apigenin, a Single Active Component of Herbal Extract, Alleviates Xerostomia via ERα-Mediated Upregulation of AQP5 Activation
title_full_unstemmed Apigenin, a Single Active Component of Herbal Extract, Alleviates Xerostomia via ERα-Mediated Upregulation of AQP5 Activation
title_short Apigenin, a Single Active Component of Herbal Extract, Alleviates Xerostomia via ERα-Mediated Upregulation of AQP5 Activation
title_sort apigenin, a single active component of herbal extract, alleviates xerostomia via erα-mediated upregulation of aqp5 activation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899471/
https://www.ncbi.nlm.nih.gov/pubmed/35264956
http://dx.doi.org/10.3389/fphar.2022.818116
work_keys_str_mv AT weiwei apigeninasingleactivecomponentofherbalextractalleviatesxerostomiaviaeramediatedupregulationofaqp5activation
AT caotingting apigeninasingleactivecomponentofherbalextractalleviatesxerostomiaviaeramediatedupregulationofaqp5activation
AT pathakjanakl apigeninasingleactivecomponentofherbalextractalleviatesxerostomiaviaeramediatedupregulationofaqp5activation
AT liuxintong apigeninasingleactivecomponentofherbalextractalleviatesxerostomiaviaeramediatedupregulationofaqp5activation
AT maotianjiao apigeninasingleactivecomponentofherbalextractalleviatesxerostomiaviaeramediatedupregulationofaqp5activation
AT watanabenobumoto apigeninasingleactivecomponentofherbalextractalleviatesxerostomiaviaeramediatedupregulationofaqp5activation
AT lixiaomeng apigeninasingleactivecomponentofherbalextractalleviatesxerostomiaviaeramediatedupregulationofaqp5activation
AT zhangmanli apigeninasingleactivecomponentofherbalextractalleviatesxerostomiaviaeramediatedupregulationofaqp5activation
AT lijiang apigeninasingleactivecomponentofherbalextractalleviatesxerostomiaviaeramediatedupregulationofaqp5activation